Skip navigation

community

Manage categories

Close

Create and manage categories in Medical Device Design & Equipment Development. Removing a category will not remove content.

Categories in Medical Device Design & Equipment Development
Add a new category (0 remaining)

Manage Announcements

Close

Create and manage announcements in Medical Device Design & Equipment Development. Try to limit the announcements to keep them useful.

Announcements in Medical Device Design & Equipment Development
Subject Author Date Actions

Ask the Expert

Featured Medical Expert
 
element14 expertJim Mettler
is head of engineering at Triad Magnetics. He is on standby ready to answer all of your medical technology questions now!
ask a question now
  See other element14 experts

Featured Video

Featured Video

Medical Solutions from Microchip

Main Banner (Log Out)

Welcome to the Medical Group
 
element14 groups Medical technology is one of the hottest areas of engineering today. From embedded microchips for subcutaneous drug delivery, to life-saving consumer electronics, medical technology is rapidly changing the face of global healthcare.
Register to learn more Already a member? login here

Recent Blog Posts

Refresh this widget
1

illu-isir04.gif

(via The Institute for Intelligent Systems and Robotics (ISIR))

 

Technology that helps robots navigate and interact with their environment may soon help blind people in much the same way. A new type of glasses that takes advantage of 3D navigation that some robots use are currently being designed by Edwige Pissaloux and his team from the Institute of Intelligent Systems and Robotics located in France. The design uses a headset imaging system that takes 3D images and sends them to a handheld device that converts it to braille that the user can read which gives the blind a different way to see their environment. The headset consists of two cameras mounted on either side of the wearer which in tandem takes 3D images. A processor then analyzes the images and identifies various objects in the cameras field of view such as walls and other objects and builds a 3D map of the area. A series of accelerometers and gyroscopes monitors the user’s location and speed to determine the wearer’s relative position in relation to the 3D map. The compiled data is then sent to a tactile feedback display that produces a constant 3D map in braille form (at a rate of ten maps per-second) the gives the user a way of ‘seeing’ their environment in real-time.

 

The IISR team in France is also looking to combine their system with software being developed by engineers at the University of Nevada that was initially used to tell robots how far they have travelled based on its sensors (accelerometer/gyroscope). Their system uses smartphones internal sensors along with available 2D in-door maps and synthetic speech (SIRI?) to help the blind navigate. In order for the system to be effective, the phone must be calibrated to the users stride. This is done touching a series of stationary markers such as walls, hallway entrances and other obstacles. Both systems combined would greatly benefit the user’s ability to navigate just about anywhere in an urban environment. As to when this system/s will become readily available is anyone’s guess but then again ‘seeing is believing’.

 

It seems the scientific community is bent on technology returning sight to the blind. Read about more efforts in the area after this link.

 

Cabe

http://twitter.com/Cabe_e14

0

Bionic-Eye.jpg

Bionic Eye concept (via Bionic Vision Australia)

 

Most of us go our days taking for granted our sense of vision, but loss of this sense changes everything. Even though vision loss can occur for many different reasons, there is little medical science can do to fix most cases of blindness. However, technology is catching up. Retinal implants are already here, and next year a computer aided “bionic” eye will be tested on a human patient.

 

 

An Australian company, Bionic Vision Australia is teaming up with scientists from a new $2.5 million facility, the Rs.12.76 Crore Fabrication Facility, found at the University of New South Wales to develop prototype bionic eyes. These first prototypes will be helpful to patients with degenerative retinal conditions. To benefit from one of these bionic eyes, patients need to have a complete and functioning visual pathway from the retina to the brain and some intact retinal cells.

 

 

These prototypes are intended to give patients limited visual capabilities. This will be accomplished by use of a chip inside the transplant, which is connected to the nerve cells in the retina that send signals to the visual cortex. Impressively, the signal is captured via a video camera found on a pair of glasses worn by the patient that wirelessly relay it to a processing computer, and even a smartphone could do the job. After processing, it is sent to the bionic eye’s chip connected to retinal cells.

 

 

The sensor is made of biocompatible material and includes 98 electrodes that stimulate surviving nerve cells. Development and manufacture of the bionic eye will be greatly accelerated at the Rs.12.76 Fabrication Facility where the two prototypes are in development. This facility is stacked with state of the art equipment including laser cutters, plasma reactors, high temperature presses, probing machines and even a “clean room” for manufacturing electrical components.

 

 

The first prototype is a “wide-view” device that will help some visually impaired to easily detect between light and dark and allow them to see outlines of big objects for easier navigation around their environment. The second prototype is a “high-acuity” bionic eye that will provide a higher definition and will allow patients to read large fonts and recognize faces. They hope to have the second prototype ready for testing in four years.

 

 

Cabe

http://twitter.com/Cabe_e14

1

111 implant in place.JPG14634_Retina_scan_showing_chip__c__Oxford_Eye_Hospital.jpg

(Left) Implant behind eye. (Right) Retinal scan showing the sensor chip in place. (via University of Oxford)

 

Diagnosed with retinitis pigmentosa, the first symptom was night blindness. A few years later, vision was drastically reduced. Finally, another disease brought complete blindness in the left eye and the inability to distinguish light on the right. Chris James, a fifty-four year old council worker in Wiltshire U.K., had his life completely changed by his complications. He said, "It’s something you have to come to terms with and make the best of what you’ve got."

 

Chris James's new eye was switched on for the first time. The digital circuits flood with electricity. James could see light against a black background for the first time in decades. The retinal implants were a success. "As soon as I had this flash in my eye, this confirmed that my optic nerves are functioning properly which is a really promising sign. It was like someone taking a photo with a flashbulb, a pulsating light, I recognized it instantly."

 

Chris James was one of the first patients (along with Robin Millar, a 60 year old music producer) suffering from retinitis pigmentosa to receive retinal implanted circuitry to detect light and images from a collaboration between the University of Oxford (UO) and the company "Retina Implants" form Germany. A team led by ophthalmology professor Robert MacLaren were able to help the patients regain some semblance of vision. As the patients continue to use the implants, their vision continues to improve. Currently, the patients can see light differences and basic shapes.

 

111 retinal implant.jpg

X-ray image of the complete system installed into Chris James. (via University of Oxford)

 

The implant is a 3mm square chip containing 1,500 light sensitive diodes. The chip is attached to the back of the eye where a signal can be sent between electrodes and the patient's optical nerves. The system is powered by an implanted power supply buried behind the ear, similar to some cochlear devices. Professor MacLaren explained that the sensor will "stimulate the overlying nerves to create a pixellated image." He continued, "Apart from a hearing aid like device behind the ear, you would not know a patient had one implanted.  We are all delighted with these initial results. The vision is different to normal , and it requires a different type of brain processing. We hope, however, that the electronic chips will provide independence for many people who are blind from retinitis pigmentosa."

 

The U.K based trials will continue with 12 patients overall thanks to funding from the National Institute of Health Research and the Oxford Biomedical Research Centre.

 

Cabe

http://twitter.com/Cabe_e14

0

technology_infographic.jpg

Technology overview (via MicroChips Inc.)

 

Daily injections of medicine may be crucial for patients who suffer from certain diseases.  However, the pain involved may deter some patients from following their prescribed regiments , and this can lead to ineffective treatment. The company Microchips Inc., along with two other commercial companies, scientists at Harvard, MIT and the Case Western Reserve are developing a microchip system that could deliver individual doses of medicine while monitoring levels in the blood wirelessly.

 

 

The device was implanted and tried successfully in seven women who suffered from postmenopausal osteoporosis.  The drug to treat osteoporosis, teriparatide, is to be injected daily for two years , and it works to build bone if given intermittently so it was the ideal candidate for preliminary testing of this device.

 

 

A single microchip is 1/15’’ thick, ½’’ long and 1/5’’ wide and is implanted using local anesthetics under the skin of the abdomen. The entire system is 2 ¼’’ long and 1 ½’’ wide and made up of two chips located on the surface of its titanium housing. Each chip contains 10 individual cubic reservoirs, each measuring 0.04 in wide, capable of holding 600 nanoliters of the medicine.

 

 

Each reservoir faces the patient’s skin and is covered with a metallic membrane made of a titanium and platinum composite. These membranes are connected to internal circuits, which deliver currents to the membranes to dissolve them and release the drug.

 

in vivo chip.jpg

A close up of how the system works (via MicroChips Inc.)

 

This drug delivery system could be used to treat multiple sclerosis and chronic pain, but limitations to this device are clear in that they cannot be used to treat Diabetics because there is not enough room in the chip to store all the insulin needed. The company estimates that it will take 2 years to develop a chip that can deliver medicine for 365 days.

 

 

Many more human trials are needed to prove this technology is safe. Microchips Inc plans to file for FDA approval in 2014 , but the device will need 2 more years of clinical studies so it will not be available commercially until late in the decade.

No toxic effects were observed in the trial, although a faulty circuit prevented the drug from being released in the 8th patient. Blood tests showed that the quantity of the automatic doses was more consistent than shots and the drug was effective in generating bone growth.

 

 

Robert Farra, President and CEO of Microchips Inc announced that the cost of the implant and treatment would be around $10,000-12,000, which is very similar to price of standard injections.

 

 

Cabe

http://twitter.com/Cabe_e14

0

Fig-1.jpg

Cochlear implant concept (via University of Utah)

 

Cochlear implants have improved the hearing for over 220,000 deaf people around the globe, but they have their drawbacks. Not being able to swim or wear helmets comfortably due to the delicate microphone and related electronics worn on the outside of the ear are just some of the tip of the limitation. A team of engineers, led by Associate Professor Darrin Young from the University of Utah, are looking to fix those issues by implanting the cochlear microphone inside the ear itself, giving the user an increased level of freedom in otherwise damaging environments.

 

Typical implants house the microphone, signal processor and transmitter coil in a plastic shroud worn behind the ear. The mic picks up sound and sends it to an internal receiver-stimulator attached to bone under the skin by the microphone housing. From there, sound is sent to electrodes attached to cochlea which in-turn stimulates auditory nerves making it possible for the user to hear. Young’s design places all the external components normally worn outside the ear inside by placing an accelerometer sensor that’s attached to a chip on the ears umbo part of the tympanic membrane to detect vibration. This converts sound into electrical signals that are then sent to the electrodes attached to the cochlea which is powered by an implanted battery enabling the user to hear.

 

Recharging the battery is done at night while the user sleeps using a charger located behind the user’s ear in much the same fashion as wearing a typical cochlear implant. Successful testing was done using several cadavers (yes, you read that right) implanted with the new cochlear system. A laser was then used to measure the vibration on bones inside the ear to see which one was more efficient at picking up normal-level sound after which it was found that the umbo was the most successful. In order to test this device, the implanted microphone was wired to speakers with Beethoven’s Ninth Symphony acting as the test medium. While the sound was ‘muffled,’ Young states that ‘the muffling can be filtered out’. The team hopes to improve the overall sound quality in future versions so clinical trials are still a few years away but anything that can assist the disabled is still a hopeful future.

 

Cabe

http://twitter.com/Cabe_e14

More

Social Media

Design Solutions

Design Solutions
Application Notes
White Papers
Training
Evaluation Kits

US,MX,CA Product Solutions

Product Solutions
Varta - 55615201501 - battery, nimh, v150h, 1.2v, 150mah
 More Info buy now
Xp power - jhm0312s12 - converter, dc/dc, medical, 3w, 12v
 More Info buy now
XP power - ecs25us12 - psu, 25w, industrial and medical
 More Info buy now

SuperWidget

More Anchor